Market Overview The global non-alcoholic fatty liver disease (NAFLD) market is experiencing growth driven by obesity prevalence, metabolic disease recognition, and treatment pipeline expansion. The NAFLD market is projected to exceed USD 32.8 billion through 2030, fueled by NAFLD patients exceeding 2 billion globally, disease progression, and therapeutic options. NAFLD treatment represents...